BNO Becoming a substantial holder (revised form) |
08/06/17 | | | Share |
|
BNO Becoming a substantial holder |
08/06/17 | | | Share |
|
BNO Ceasing to be a substantial holder |
07/06/17 | | | Share |
|
BNO Bionomics Corporate Presentation May 2017 |
31/05/17 | PRICE SENSITIVE | | Share |
|
BNO Bionomics NOW Newsletter May 2017 |
29/05/17 | | | Share |
|
BNO Bionomics Recruits International Executive as CFO |
24/05/17 | | | Share |
|
BNO BNC210 Clinical Data Presented at US Psychiatry Convention |
18/05/17 | PRICE SENSITIVE | | Share |
|
BNO Bionomics to Host KOL Meeting Focused on BNC210 in London |
10/05/17 | | | Share |
|
BNO Appendix 4C - quarterly |
26/04/17 | PRICE SENSITIVE | | Share |
|
BNO Bionomics Presents Promising BNC101 Data at AACR Conference |
03/04/17 | | | Share |
|
BNO Webcast Available of KOL Meeting |
24/03/17 | | | Share |
|
BNO Bionomics to Host KOL Meeting on PTSD & Anxiety in New York |
20/03/17 | | | Share |
|
BNO Appendix 3B |
13/03/17 | | | Share |
|
BNO Bionomics to Present at 29th Annual ROTH Conference |
10/03/17 | | | Share |
|
BNO Ceasing to be a substantial holder from CVC |
24/02/17 | | | Share |
|
BNO Change in substantial holding |
24/02/17 | | | Share |
|
BNO Becoming a substantial holder |
24/02/17 | | | Share |
|
BNO Change in substantial holding |
24/02/17 | | | Share |
|
BNO New BNC105 Clinical Trial in Combination with Keytruda |
20/02/17 | PRICE SENSITIVE | | Share |
|
BNO Half Yearly Report and Accounts |
17/02/17 | PRICE SENSITIVE | | Share |
|
BNO MSD Cognition Program Milestone Payment |
03/02/17 | PRICE SENSITIVE | | Share |
|
BNO Appendix 4C - quarterly |
31/01/17 | PRICE SENSITIVE | | Share |
|
BNO Bionomics Presents at Biotech Showcase 2017 |
09/01/17 | | | Share |
|
BNO Appendix 3B |
12/12/16 | | | Share |
|
BNO Warrants Update |
12/12/16 | | | Share |
|
BNO Change of Director's Interest Notice |
28/11/16 | | | Share |
|
BNO Change of Director's Interest Notice |
28/11/16 | | | Share |
|
BNO Change of Director's Interest Notice |
28/11/16 | | | Share |
|
BNO Change of Director's Interest Notice |
28/11/16 | | | Share |
|
BNO Change of Director's Interest Notice |
28/11/16 | | | Share |
|
BNO Appendix 3B |
28/11/16 | | | Share |
|
BNO Appendix 3B |
16/11/16 | | | Share |
|
BNO BNO to Present at Society for Neuroscience Annual Meeting |
16/11/16 | | | Share |
|
BNO Final Director's Interest Notice |
10/11/16 | | | Share |
|
BNO Results of Meeting |
08/11/16 | | | Share |
|
BNO CEO & Managing Director's Report to Shareholders |
08/11/16 | PRICE SENSITIVE | | Share |
|
BNO Chairman's Address Bionomics Annual General Meeting 2016 |
08/11/16 | | | Share |
|
BNO Appendix 3B |
04/11/16 | | | Share |
|
BNO Bionomics and MSD Annual Symposium |
04/11/16 | | | Share |
|
BNO Appendix 4C - quarterly-BNO.AX |
31/10/16 | PRICE SENSITIVE | | Share |
|
BNO BNO to Present at International Biotechnology Symposium-BNO.AX |
25/10/16 | | | Share |
|
BNO Upcoming Investor Presentations-BNO.AX |
24/10/16 | | | Share |
|
BNO Appendix 4G / Corporate Governance Statement-BNO.AX |
07/10/16 | | | Share |
|
BNO Bionomics Annual Report 2016-BNO.AX |
07/10/16 | | | Share |
|
BNO Notice of General Meeting/Proxy Form-BNO.AX |
07/10/16 | | | Share |
|
BNO Change of Director's Interest Notice-BNO.AX |
06/10/16 | | | Share |
|
BNO Appendix 3B-BNO.AX |
06/10/16 | | | Share |
|
BNO BNO to Present at Ladenburg Thalmann Healthcare Conference-BNO.AX |
26/09/16 | | | Share |
|
BNO BNO BNC210 GAD Trial Results Investor Call Replay-BNO.AX |
22/09/16 | | | Share |
|
BNO Positive BNC210 Phase 2 Anxiety Trial Results-BNO.AX |
21/09/16 | PRICE SENSITIVE | | Share |
|
BNO Trading Halt-BNO.AX |
19/09/16 | PRICE SENSITIVE | | Share |
|
BNO BNC210 Data to be Presented at ECNP-BNO.AX |
16/09/16 | PRICE SENSITIVE | | Share |
|
BNO Change of Director's Interest Notice-BNO.AX |
15/09/16 | | | Share |
|
BNO BNO to Present at Rodman & Renshaw Global Investment Conf.-BNO.AX |
12/09/16 | | | Share |
|
BNO Change of Director's Interest Notice-BNO.AX |
01/09/16 | | | Share |
|
BNO Final Director's Interest Notice-BNO.AX |
01/09/16 | | | Share |
|
BNO Initial Director's Interest Notice-BNO.AX |
01/09/16 | | | Share |
|
BNO Bionomics Appoints Alan Fisher Non-Executive Director-BNO.AX |
31/08/16 | | | Share |
|
BNO Change in substantial holding-BNO.AX |
28/08/16 | | | Share |
|
BNO Change in substantial holding-BNO.AX |
26/08/16 | | | Share |
|
BNO Appendix 3B-BNO.AX |
19/08/16 | | | Share |
|
BNO Appendix 3Y-BNO.AX |
19/08/16 | | | Share |
|
BNO Change of Director's Interest Notice-BNO.AX |
17/08/16 | | | Share |
|
BNO Withdrawal of Intention to Call General Meeting,CVC-BNO.AX |
15/08/16 | | | Share |
|
BNO Board Changes and Conclusion of Governance Review-BNO.AX |
09/08/16 | | | Share |
|
BNO Full Year Statutory Accounts-BNO.AX |
09/08/16 | | | Share |
|
BNO Bionomics 2015/2016 Preliminary Final Results-BNO.AX |
09/08/16 | PRICE SENSITIVE | | Share |
|
BNO Board and Shareholder Meetings-BNO.AX |
03/08/16 | | | Share |
|
BNO Appendix 4C - quarterly-BNO.AX |
29/07/16 | PRICE SENSITIVE | | Share |
|
BNO Bionomics to present at upcoming US Investor Conference-BNO.AX |
12/07/16 | | | Share |
|
BNO Final Director's Interest Notice-BNO.AX |
08/07/16 | | | Share |
|
BNO Appendix 3B-BNO.AX |
04/07/16 | | | Share |
|
BNO Director Retirement and Informal Board-Shareholder Meetings-BNO.AX |
04/07/16 | | | Share |
|
BNO Appendix 3B-BNO.AX |
30/06/16 | | | Share |
|
BNO BNO To Trial Drug Against Post-Traumatic Stress Disorder-BNO.AX |
30/06/16 | PRICE SENSITIVE | | Share |
|
BNO Enrolment Completed in Generalised Anxiety Disorder Trial-BNO.AX |
24/06/16 | PRICE SENSITIVE | | Share |
|
BNO Enrolment Completed in Generalised Anxiety Disorder Trial-BNO.AX |
24/06/16 | PRICE SENSITIVE | | Share |
|
BNO Bionomics Receives Share of Funds from CTx License Deal-BNO.AX |
23/06/16 | PRICE SENSITIVE | | Share |
|
BNO Initial Director's Interest Notice-BNO.AX |
21/06/16 | | | Share |
|
BNO Initial Director's Interest Notice-BNO.AX |
21/06/16 | | | Share |
|
BNO Bionomics Strengthens Board-BNO.AX |
16/06/16 | | | Share |
|
BNO Appendix 3B-BNO.AX |
15/06/16 | | | Share |
|
BNO Appendix 3B-BNO.AX |
06/05/16 | | | Share |
|
BNO Bionomics Corporate Presentation May 2016-BNO.AX |
03/05/16 | | | Share |
|
BNO Appendix 4C - quarterly-BNO.AX |
29/04/16 | PRICE SENSITIVE | | Share |
|
BNO BNC105 Cancer Immune Activation Data Presented at AACR-BNO.AX |
20/04/16 | PRICE SENSITIVE | | Share |
|
BNO Update on Board Recruitment Process-BNO.AX |
14/04/16 | | | Share |
|
BNO Change in substantial holding-BNO.AX |
08/04/16 | | | Share |
|
BNO Bionomics Initiates Phase 1 Study of BNC101-BNO.AX |
04/04/16 | PRICE SENSITIVE | | Share |
|
BNO Notice Under Section 203D |
16/03/16 | | | Share |
|
BNO Appendix 3B |
10/03/16 | | | Share |
|
BNO Bionomics to Present at Upcoming U.S. Investor Conferences |
08/03/16 | | | Share |
|
BNO Shareholder Consultation Process |
07/03/16 | | | Share |
|
BNO Results of Meeting |
04/03/16 | | | Share |
|
BNO Results of Meeting |
03/03/16 | | | Share |
|
BNO For Further Information, Black Scholes Valuation |
25/02/16 | | | Share |
|
BNO Half Yearly Report and Accounts |
18/02/16 | PRICE SENSITIVE | | Share |
|
BNO Board Update |
17/02/16 | | | Share |
|
BNO Becoming a substantial holder from CVC |
04/02/16 | | | Share |
|
BNO Notice of Extraordinary General Meeting/Proxy Form |
01/02/16 | | | Share |